» Articles » PMID: 6289139

A Novel Analysis of Concentration-dependence of Partial Agonism Ring-demethylation of Bupranolol Results in a High Affinity Partial Agonist (K 105) for Myocardial and Tracheal Beta-adrenoceptors

Overview
Specialty Pharmacology
Date 1982 Aug 1
PMID 6289139
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

1. Ring-demethylation of the pure antagonist bupranolol results in a ligand (K 105) which induces conformational beta-adrenoceptor changes leading to partial agonistic effects in heart and trachea. However, these conformational receptor changes are not accompanied by changes in receptor affinity, because the affinity estimates for K 105 and bupranolol did not differ for a variety of myocardial tissues (including ventricular beta-adrenoceptors labelled with 3H-(-)-propranolol] and trachea, not even for tracheal receptor subtypes. 2. For the analysis of the concentration-dependence of the blocking actions of a partial agonist a double log-plot was derived, which includes the classical Schild-plot as a special case. The plot is based on the statistical analysis of the action of partial agonists by Marano and Kaumann (1976). They defined a slope m for the weighted regression of equieffective concentrations of agonist in the absence and presence of a concentration [P] of partial agonist P. We derived the dependence of m on [P], which is suitably expressed as: log (1/m-1) = log [P]-log Kp. For the case of a single class of non-interacting receptors the slope of the double log-regression should be unity. Our plot has incorporated information from complete concentration-effect curves, instead of a single concentration-ratio as in the Schild-plot. Analysis of data of K 105 with the new plot (intrinsic activity greater than 0) and the Schild-plot (intrinsic activity = 0) yielded slopes near unity, consistent with simple competition.

Citing Articles

An estimation of beta 2-adrenoceptor reserve on human bronchial smooth muscle for some sympathomimetic bronchodilators.

Giembycz M Br J Pharmacol. 2009; 158(1):287-99.

PMID: 19466988 PMC: 2795251. DOI: 10.1111/j.1476-5381.2009.00277.x.


Atypical cardiostimulant beta-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues.

Malinowska B, Kiec-Kononowicz K, Flau K, Godlewski G, Kozlowska H, Kathmann M Br J Pharmacol. 2003; 139(8):1548-54.

PMID: 12922943 PMC: 1573984. DOI: 10.1038/sj.bjp.0705390.


Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.

Sarsero D, Molenaar P, Kaumann A, Freestone N Br J Pharmacol. 1999; 128(7):1445-60.

PMID: 10602323 PMC: 1571781. DOI: 10.1038/sj.bjp.0702936.


Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.

Kaumann A, Molenaar P Br J Pharmacol. 1996; 118(8):2085-98.

PMID: 8864547 PMC: 1909870. DOI: 10.1111/j.1476-5381.1996.tb15648.x.


Characterization of the 5-HT4 receptor mediating tachycardia in piglet isolated right atrium.

Medhurst A, Kaumann A Br J Pharmacol. 1993; 110(3):1023-30.

PMID: 8298790 PMC: 2175817. DOI: 10.1111/j.1476-5381.1993.tb13916.x.


References
1.
Kaumann A, BLINKS J . beta-Adrenoceptor blocking agents as partial agonists in isolated heart muscle: dissociation of stimulation and blockade. Naunyn Schmiedebergs Arch Pharmacol. 1980; 311(3):237-48. DOI: 10.1007/BF00569403. View

2.
Morris T, Sandrock K, Kaumann A . 3H-(-)-Bupranolol, a new beta-adrenoceptor radioligand: characterization of its binding to kitten heart beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1981; 317(1):19-25. DOI: 10.1007/BF00506251. View

3.
Bearer C, Knapp R, Kaumann A, Swartz T, Birnbaumer L . Iodohydroxybenzylpindolol: preparation, purification, localization of its iodine to the indole ring, and characterization as a partial agonist. Mol Pharmacol. 1980; 17(3):328-38. View

4.
Kaumann A . Potentiation of the effects of isoprenaline and noradrenaline by hydrocortisone in cat heart muscle. Naunyn Schmiedebergs Arch Pharmacol. 1972; 273(1):134-53. DOI: 10.1007/BF00508086. View

5.
Kaumann A . In kitten ventricular myocardium, the inotropic potency of an agonist is determined by both its intrinsic activity for the adenylyl cyclase and its affinity for the beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1981; 317(1):13-8. DOI: 10.1007/BF00506250. View